Azura Genomics

Azura Genomics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Azura Genomics is a private, commercial-stage company providing essential molecular biology reagents and consumables to the life sciences research and diagnostics markets. Leveraging over 20 years of experience in amplification technology, the company has built a portfolio centered on proprietary, optimized formulations that promise improved sensitivity, stability, and workflow simplicity. Operating a direct-to-customer e-commerce model from San Diego, Azura generates revenue through the sale of its branded reagent kits and its PURline consumables, while also offering custom OEM and bulk solutions. The company positions itself as a value-driven alternative to larger suppliers in the crowded but critical PCR reagents market.

Genetics & GenomicsDiagnostics

Technology Platform

Proprietary formulations for PCR and qPCR mastermixes and enzymes, featuring optimized buffers with novel additives for complex samples, improved stability, low background DNA, stringent hot-start, and integrated workflow solutions for sensitivity and ease-of-use.

Opportunities

The growing global demand for reliable, cost-effective PCR reagents in research and diagnostics, especially for sensitive applications like viral detection, presents a core opportunity.
Expanding the OEM/white-label business and the high-margin, recurring revenue from consumables (PURline) offer significant avenues for scalable growth.

Risk Factors

Intense competition from large, established life science tools corporations poses a major threat to market penetration and pricing.
The company is also vulnerable to supply chain disruptions for critical raw materials and is highly dependent on the continued dominance of PCR technology in molecular biology.

Competitive Landscape

Azura competes in the crowded life science reagents market against giants like Thermo Fisher Scientific, Bio-Rad, and Qiagen, as well as numerous other specialized and generic suppliers. Its strategy is to differentiate on a value proposition of high sensitivity and ease-of-use at a competitive price point, targeting customers who may find premium brands cost-prohibitive or seek alternatives.